Company Quick10K Filing
Plyzer Technologies
10-Q 2019-12-31 Filed 2020-04-06
10-Q 2019-09-30 Filed 2019-11-18
10-Q 2019-06-30 Filed 2019-09-12
10-K 2019-03-31 Filed 2019-08-02
10-Q 2018-12-31 Filed 2019-02-14
10-Q 2018-09-30 Filed 2018-11-19
10-Q 2018-06-30 Filed 2018-08-21
10-K 2018-03-31 Filed 2018-07-12
10-Q 2017-12-31 Filed 2018-02-16
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-21
10-K 2017-03-31 Filed 2017-06-29
10-Q 2016-12-31 Filed 2017-02-08
10-Q 2016-09-30 Filed 2016-11-03
10-Q 2016-06-30 Filed 2016-08-15
10-K 2016-03-31 Filed 2016-06-28
10-Q 2015-12-31 Filed 2016-02-04
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-12
10-K 2015-03-31 Filed 2015-07-16
10-Q 2014-12-31 Filed 2015-02-17
10-Q 2014-09-30 Filed 2014-11-17
10-Q 2014-06-30 Filed 2014-08-15
10-K 2014-03-31 Filed 2014-06-30
10-Q 2014-02-18 Filed 2014-02-18
10-Q 2013-08-14 Filed 2013-08-14
10-K 2013-03-31 Filed 2013-07-09
10-Q 2013-02-19 Filed 2013-02-19
10-Q 2012-11-21 Filed 2012-11-21
10-Q 2012-08-03 Filed 2012-08-13
10-K 2012-03-31 Filed 2012-06-22
10-Q 2011-12-31 Filed 2012-02-14
10-Q 2011-09-30 Filed 2011-11-07
10-Q 2011-06-30 Filed 2011-08-05
10-K 2011-03-31 Filed 2011-06-27
10-Q 2010-12-31 Filed 2011-02-15
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-16
10-K 2010-03-31 Filed 2010-07-14
10-Q 2009-12-31 Filed 2010-02-16
8-K 2020-11-13
8-K 2020-08-11
8-K 2020-06-17
8-K 2020-01-07
8-K 2019-06-20
8-K 2018-10-24
8-K 2018-09-26
8-K 2018-01-26

Plyzer Technologies Financials

PLYZ Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-11-212013-02-192013-03-312013-08-142013-09-302014-02-182014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash10082453274534721271712881104018410326239207218183262189
Accounts Receivable377
Inventory
PP&E434554336675
Assets1104414875065075055055775696196571161131011398111710744211028358261234207654606
Accounts Payable
Long-Term Debt10325325325325325325
Liabilities1511534044450752853954654457464277689545346244945212311382871603865675001,3991,5581,8691,5142,7305,1663,704
Stockholders' Equity-150-152-40-3-20-22-32-40-393-74-157-238-337-349-348-439-114-104-81-87-143-278-125-390-1,116-1,501-1,607-1,280
Income Statement ($'000)2011-09-302011-12-312012-03-312012-11-212013-02-192013-03-312013-08-142013-09-302014-02-182014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue000000000000000000000000000000343
Cost of Revenue
Gross Profit
R&D
SG&A0214441221710232253222115119111712211338248151
Tax00000000000000000
Net Income2-3112-22-15-9-13-3-5-65-66-85-91-2,088-55-31-136-499-1826-10-69-136-144-480-1,050-387-20,946-1,516-2,577-3,116-2,191
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-11-212013-02-192013-03-312013-08-142013-09-302014-02-182014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-2116-31-27-10-6-24-71-11314-65-26-8-7-2-1-4-8-71-155-239-125-395-349-424-780-594-1,155
Cash Investing-52-170000-48-2-4710-2-40-1-2-155-10
Cash Financing2-116-276192413-0896111166835-50071199380465621255917448291,094